NCRI Partnership’s work to promote communication, coordination and collaboration in cancer research is as strong as ever.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 17, 2022
SURGE Therapeutics
|
Series A | $26M | Biotechnology | — |
Jul 19, 2022
Cartography Biosciences
|
Series A | $57M | Biopharma | — |
Oct 18, 2018
The Case Comprehensive Cancer Center (Case CCC)
|
Grant | $3.20M | Charity | Yes |
Aug 13, 2018
Agilvax
|
Grant | $2.30M | Biotechnology | — |